Table 3.
Comparison of features of renal Anastomosing Hemangiomas between patients with end-stage renal disease (ESRD) and patients without ESRD.
| All patients (n=100) | With ESRD (n=46) | Without ESRD (n=54) | p | |
|---|---|---|---|---|
| Age (Mean ± SD) | 50.32 ± 16.96 | 44.34 ± 14.73 | 55.41 ± 17.19 | 0.001 |
| Gender (n, %) | ||||
| Female | 32 (32.0%) | 16 (34.8%) | 16 (29.6%) | 0.582 |
| Male | 68 (68.0%) | 30 (65.2%) | 38 (70.5%) | |
| Clinical Manifestation (n, %) | ||||
| Absent | 83 (83.0%) | 40 (87.0%) | 43 (79.6%) | 0.363 |
| Present | 17 (17.0%) | 6 (13.0%) | 11 (20.4%) | |
| Site (n, %) | ||||
| Left | 40 (40.0%) | 13 (28.3%) | 27 (50.0%) | <0.001 |
| Right | 31 (31.0%) | 11 (23.9%) | 20 (37.0%) | |
| Bilateral | 11 (11.0%) | 11 (23.9%) | 0 (0.0%) | |
| Unknown | 18 (18.0%) | 11 (23.9%) | 7 (13.0%) | |
| Location (n, %) | ||||
| Renal cortex | 5 (5.0%) | 2 (4.3%) | 3 (5.6%) | 0.943 |
| Renal sinus/hilus/medulla | 35 (35.0%) | 15 (32.6%) | 20 (37.0%) | |
| Renal sinus/hilus/medulla and cortex | 11 (11.0%) | 5 (10.9%) | 6 (11.1%) | |
| Unknown | 49 (49.0%) | 24 (52.2%) | 25 (46.3%) | |
| Focality (n, %) | ||||
| Unifocal | 61 (61.0%) | 19 (41.3%) | 42(77.8%) | <0.001 |
| Multifocal | 25 (25.0%) | 23 (50.0%) | 2 (3.7%) | |
| Unknown | 14 (14.0%) | 4 (8.7%) | 10 (18.5%) | |
| Largest Tumor Diameter (mm) (n=81) | 24.72 ± 22.31 | 16.79 ± 13.62 | 33.26 ± 26.51 | 0.001 |
| Preoperative misdiagnosis (n=21) | 21 (100.0%) | 5 (23.8%) | 16 (76.2%) | |
| Surgery approach (n, %) (n=91) | ||||
| Partial nephrectomy | 20 (22.0%) | 2 (4.5%) | 18 (38.3%) | <0.001 |
| Radical nephrectomy | 71 (78.0%) | 42 (95.5%) | 29 (61.7%) | |
| Cooccurrence/History of other renal tumors (n=24) | 24 (100.0%) | 18 (75.0%) | 6 (25.0%) | |
Significant values are in bold.